Advanced search
Publication Cover
Microbial Ecology in Health and Disease Volume 23, 2012 - Issue 1
Journal homepage
238
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

A ten years (2000–2009) surveillance of resistant Enterobacteriaceae in Zhejiang Province, China

Rong ZhangSecond Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, China;Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
,
Tomoaki IchijoSecond Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, China
,
Yan-Yan HuSecond Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, China
,
Hong-Wei ZhouSecond Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, China
,
Nobuyasu YamaguchiGraduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
,
Masao NasuGraduate School of Pharmaceutical Sciences, Osaka University, Osaka, JapanCorrespondence[email protected]
&
Gong-Xiang ChenSecond Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, China
 show all
Article: 11609 | Received 07 Nov 2011, Accepted 20 Jan 2012, Published online: 23 Mar 2012

References

  • Wang F, Zhu DM, Hu FP, Ruan FY, Ni YX, Sun JY, et al. CHINET 2008 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2009; 9: 321–9.
  • Wang F. CHINET 2005 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2006; 6: 289–95.
  • Wang F. CHINET 2006 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2008; 8: 1–9.
  • Wang F, Zhu DM, Hu FP, Ruan FY, Ni YX, Sun JY, et al. CHINET 2007 surveillance of bacterial resistance in China. Chin J Infect Chemother. 2008; 8: 325–33.
  • Farrell DJ, Turnidge JD, Bell J, Sader HS, Jones RN. The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008). J Infect. 2010; 60: 440–51.
  • Hoban DJ, Bouchillon SK, Hawser SP, Badal RE. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn Microbiol Infect Dis. 2010; 66: 78–86.
  • Nord CE, Lindmark A, Persson I. Susceptibility of anaerobic-bacteria to meropenem. J Antimicrob Chemother. 1989; 24: 113–7.
  • Yang YJ, Bhachech N, Bush K. Biochemical-comparison of imipenem, meropenem and biapenem-permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases. J Antimicrob Chemother. 1995; 35: 75–84.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Available from: http://www.clsi.org/source/orders/free/m100-s20.pdf.
  • Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001; 45: 1151–61.
  • Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother. 2008; 52: 2014–18.
  • Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10: 597–602.
  • Nijssen S, Florijn A, Bonten MJM, Schmitz FJ, Verhoef J, Fluit AC. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents. 2004; 24: 585–91.
  • Rhomberg PR, Jones RN. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008). Diagn Microbiol Infect Dis. 2009; 65: 414–26.
  • Pfaller MA, Sader HS, Fritsche TR, Jones RN. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis. 2006; 56: 63–8.
  • Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007; 20: 440–58.
  • Castanheira M, Deshpande LM, DiPersio JR, Kang J, Weinstein MP, Jones RN. First descriptions of bla(KPC) in Raoultella spp. (R. planticola and R. ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol. 2009; 47: 4129–30.
  • Robledo IE, Aquino EE, Sante MI, Santana JL, Otero DM, Leon CF, et al. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother. 2010; 54: 1354–57.
  • Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007; 51: 763–5.
  • Zhang R, Zhou HW, Cai JC, Chen GX. Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother. 2007; 59: 574–6.
  • Zhang R, Zhou HW, Cai JC, Zhang J, Chen GX, Nasu M, et al. Serotypes and extended-spectrum beta-lactamase types of clinical isolates of Shigella spp. from the Zhejiang province of China. Diagn Microbiol Infect Dis. 2011; 69: 98–104.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.